FindTrial
Sign In

Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery in Soba Hospital Sudan

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01347593
Enrollment
220
Registered
2011-05-04
Start date
2011-05-31
Completion date
2011-08-31
Last updated
2013-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean

Keywords

ceftizoxime, Cesarean, post caesarean febrile morbidity

Brief summary

Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.

Interventions

DRUGceftizoxime

ceftizoxime (cefizox) injection either after clamping the cord

Sponsors

Ministry of Health, Sudan
CollaboratorUNKNOWN
University of Khartoum
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Elective Cesarean section

Exclusion criteria

* Diabetes severe anaemia allergy

Design outcomes

Primary

MeasureTime frameDescription
reducing post Cesarean section febrile morbidity4 daysreducing infection rate

Countries

Sudan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026